Clinical Study - Ref20C15

A pilot study on the liver protective effect of silybinphosphatidylcholine complex(Siliphos®) in chronic active hepatitis

G. Buzzelli, S1., Moscarella, A. 1, Giusti, A. 1, Duchini, C. 1, Marena and M.Lampertico 2,1

1.Instituto di Clinica Medica , Universita Degli Studi di Firenze, Firenze and2. Medical Department, Inverni Dell Beffa, Milan Italy

Int. J. Clin. Pharmacol. Ther. Toxicol. 31, 456 (1993)

See National Library of Medicine Citation

This was a 20 patient study. 10 patients were treated and 10 were given a placebo. Liver enzyme levels were reduced by 20-30% on average with just one week of usage.Inconclusion, IdB 1016 (Siliphos®) seems to improve the biochemical signs ofhepatocellular necrosis and/or increases cellular permeability in patients affectedby chronic active hepatitis.

This chart shows the dramatic decrease in elevated liver enzymes in patients with chronic active hepatitis after just 7 days of using the active ingredient in Maximum Milk Thistle® daily.